Identity DNA testing laboratory Orchid Cellmark (Princeton, NJ) has agreed to acquire the outstanding stock of ReliaGene Technologies (New Orleans, LA) for a purchase price of $5.6 million in cash and $3 million in Orchid stock. The deal is expected to close by the beginning of this month.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

November 2007 - Table of Contents

LIR November 2007 (full PDF issue)

San Diego Is First Site for Lab Competitive Bidding Demo Project

Vista Equity Partners Closes on Purchase of Misys Diagnostic Systems

Blogs Keep Busy Labs Updated

CAP, ACLA Call for Public Disclosure of "Medically Unlikely Edits"

Orchid Cellmark to Buy New Orleans DNA Testing Lab for $8.6M

Surviving the Price War: Lab Experts Weigh In

G-2 Award Winners Honored at Lab Institute

Lab Stocks Up 19% Year to Date

G-2 Welcomes New Editor Julie McDowell

The Impact of Falling Reimbursement